Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 293

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 293
---
 - “ Alpha Tau Medical Inc.” (“ ATM Inc.”). ATM Inc.
began its activity in August 2018.

In January 2018
the Company established a subsidiary in Japan “ Alpha Tau Medical KK” (“ ATM KK”). ATM KK began its activity in January
2018. Since July 2019, the Company holds100% of ATM KK.

In July 2019, the
Company established a fully owned subsidiary in Canada “ Alpha Tau Medical Canada Inc.” (“ ATM Canada Inc.”). ATM
Canada Inc. began its activity in March 2020.

  Merger with Healthcare Capital Corp:  

On July 7,
2021, the Company entered into an Agreement and Plan of Merger (the “ Merger Agreement”) with Healthcare Capital Corp., a Delaware
corporation (“ HCCC”), and Archery Merger Sub Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“ Merger
Sub”). As result of the Merger Agreement, the Merger Sub was merged with and into HCCC (the “ Merger”) on March 7, 2022
(the “ Closing Date”), with HCCC surviving the merger as a wholly owned subsidiary of the Company and the Company’s Ordinary
shares, no par value per share and Public and Private Warrants (see note 8) began trading on the Nasdaq Capital Market on March 8, 2022.

Concurrently with
and following the execution of the Merger Agreement, the Company entered into Subscription Agreements, together with a number of subsequent
agreements since with certain investors (the “ PIPE Investors”), in which the Company consummated the sale of9,251,006Ordinary
shares for gross proceeds of $92,510.

Total gross proceeds
resulted from the Merger transaction were approximately $104,052, out of which total transaction costs amounted to approximately $5,713.
The transaction costs related to the Warrants liability in the amount of $817were recognized as expenses in the Company’s consolidated
statements of operations. The residual amount was recognized as additional paid in capital.

The Merger has been
accounted for as a recapitalization, with no goodwill or other intangible assets recorded. It has been determined that the Company is
the accounting acquirer.

  The Company’s activities since inception have consisted of performing research and development activities.                                      

F-8

ALPHA TAU
MEDICAL LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED FIN